Robert E. Gagnon
Chief Financial Officer
Chief Financial Officer at Opus Genetics, Inc., filing insider transactions between 2026-07-23 and 2026-10-23.
Total Purchases
—
0 transactions
Total Sales
$200K
3 transactions
Companies Traded
1
3 total filings
Active Since
2026-07-23
Last: 2026-10-23
Other Reporting Insiders at Opus Genetics, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-10-23 | IRD | Sale | 14.0K | $3.55 | $50K | 542.4K | SEC ↗ |
| 2026-09-03 | IRD | Sale | 28.0K | $4.54 | $127K | 556.4K | SEC ↗ |
| 2026-07-23 | IRD | Sale | 7,783 | $2.95 | $23K | 584.4K |
Head of Fin. Quality Assurance